Dengue and dengue vaccines

被引：25

作者：

Edelman, R ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2005年 / 191卷 / 05期

关键词：

D O I：

10.1086/427784

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：650 / 653

页数：4

共 45 条

[1]

Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3

[2] CORRELATION OF E-PROTEIN BINDING WITH CELL SUSCEPTIBILITY TO DENGUE-4 VIRUS-INFECTION [J].

ANDERSON, R ;

KING, AD ;

INNIS, BL .

JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2155-2159

[3] ChimeriVax-West Nile virus live-attenuated vaccine: Preclinical evaluation of safety, immunogenicity, and efficacy [J].

Arroyo, J ;

Miller, C ;

Catalan, J ;

Myers, GA ;

Ratterree, MS ;

Trent, DW ;

Monath, TP .

JOURNAL OF VIROLOGY, 2004, 78 (22) :12497-12507

[4] DENGUE VIRUS TYPE-2 VACCINE - REACTOGENICITY AND IMMUNOGENICITY IN SOLDIERS [J].

BANCROFT, WH ;

SCOTT, RM ;

ECKELS, KH ;

HOKE, CH ;

SIMMS, TE ;

JESRANI, KDT ;

SUMMERS, PL ;

DUBOIS, DR ;

TSOULOS, D ;

RUSSELL, PK .

JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06) :1005-1010

[5] DENGUE-2 VACCINE - VIROLOGICAL, IMMUNOLOGICAL, AND CLINICAL-RESPONSES OF 6 YELLOW-FEVER IMMUNE RECIPIENTS [J].

BANCROFT, WH ;

TOP, FH ;

ECKELS, KH ;

ANDERSON, JH ;

MCCOWN, JM ;

RUSSELL, PK .

INFECTION AND IMMUNITY, 1981, 31 (02) :698-703

[6] Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine [J].

Beasley, DWC ;

Li, L ;

Suderman, MT ;

Guirakhoo, F ;

Trent, DW ;

Monath, TP ;

Shope, RE ;

Barrett, ADT .

VACCINE, 2004, 22 (27-28) :3722-3726

[7] Live attenuated tetravalent dengue vaccine [J].

Bhamarapravati, N ;

Sutee, Y .

VACCINE, 2000, 18 :44-47

[8] A PROSPECTIVE-STUDY OF DENGUE INFECTIONS IN BANGKOK [J].

BURKE, DS ;

NISALAK, A ;

JOHNSON, DE ;

SCOTT, RM .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1988, 38 (01) :172-180

[9] Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries [J].

DeRoeck, D ;

Deen, J ;

Clemens, JD .

VACCINE, 2003, 22 (01) :121-129

[10] rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers [J].

Durbin, AP ;

Whitehead, SS ;

McArthur, J ;

Perreault, JR ;

Blaney, JE ;

Thumar, B ;

Murphy, BR ;

Karron, RA .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :710-718

← 1 2 3 4 5 →